The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study

BACKGROUND: Biologics targeting inflammatory mediators can achieve clinical improvements in hidradenitis suppurativa (HS). However, their clinical efficacy shows great interpatient variability in daily practice. OBJECTIVES: To investigate the anti‐inflammatory potency of a selection of currently ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Vossen, A.R.J.V., Ardon, C.B., van der Zee, H.H., Lubberts, E., Prens, E.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850593/
https://www.ncbi.nlm.nih.gov/pubmed/30657173
http://dx.doi.org/10.1111/bjd.17641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850593/
https://www.ncbi.nlm.nih.gov/pubmed/30657173
http://dx.doi.org/10.1111/bjd.17641

Ejemplares similares